The effect of adalimumab on the vasculature in psoriatic skin lesions by S. C. A. Hanssen, C. J. M. van der Vleuten, P. E. J. van Erp, M. M. B. Seyger, P. C. M. van de Kerkhof

Get full text

National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure by L. S. van der Schoot, E. M. Baerveldt, W. A. van Enst, S. P. Menting, M. M. B. Seyger, S. L. Wanders, I. van Ee, A. H. Pieterse, J. M. P. A. van den Reek, E. M. G. J. de Jong

Get full text

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice by L.S. van der Schoot, J.J. Janssen, M.T. Bastiaens, A. de Boer-Brand, C. Christiaansen-Smit, D.N.H. Enomoto, R. Hovingh, R.A. Tupker, M.M.B. Seyger, L.M. Verhoef, J.M.P.A. van den Reek, E.M.G.J. de Jong

Get full text